Goosehead Insurance, Inc

Aggregates views from 12 Wall Street analysts into a consensus Buy rating with an average price target of 72.33, highlighting Goosehead’s technology-driven growth strategy, digital agent model, and expansion outside Texas while noting valuation sensitivity to growth expectations, inflation, interest rates, and competitive/AI disruption risks.

Frames GSHD as a “de-rated insurance-distribution compounder” in a broken longer-term downtrend, describing the current move into the low‑50s as a countertrend bounce off 33.68, laying out detailed bull and bear cases around Q2 2026 earnings, revenue-growth guidance (10–19%), producer exits/launches, and technical triggers such as a weekly close below 44, and treating new entries as highly tactical rather than a clear long-term buy.

Argues that despite a roughly 58% one-year share-price decline, Goosehead’s accelerating Q1 2026 revenue growth (23%), margin expansion (adjusted EBITDA margin 26%), AI-enabled efficiency, and Digital Agent 2.0 platform support a valuation model projecting the stock to reach 91.22 by December 2028, implying about 110% total return and ~34% annualized upside, while highlighting scenario-based risks tied to housing activity, retention, and further multiple compression.

Provides a full-length fundamental report on Goosehead’s asset-light franchise and corporate-agent model, Q1 2026 beat on EPS and EBITDA (GAAP net income 8.0 million, adjusted EBITDA 24.4 million, margin 26%), and five‑year valuation scenarios that yield a probability‑weighted target of 76.01 (about 106% upside), alongside an extensive risk section covering producer productivity, leverage, housing/interest-rate sensitivity, commission pressure, and regulatory changes.

Reviews a sharp recent share-price slide (double‑digit declines over one and three months) and compares Goosehead’s modeled fair value against its current price, concluding that while the stock appears materially undervalued on discounted cash-flow metrics, it still trades on a high P/E relative to industry and peers, so investors should balance upside from earnings growth and housing normalization against valuation, leverage, and execution risks.

Analyzes Goosehead’s nearly 58% one-year share-price drop alongside its positive revenue (about 353 million) and net income profile (~30 million), noting that a popular fair-value estimate around 91.55 per share implies significant undervaluation versus a recent price near 48.69, but emphasizing that the stock still trades at a P/E far above insurance-sector and peer averages, leaving limited room for disappointment in future growth.

Brief investment letter portraying Goosehead as a high‑margin, capital‑light personal‑lines broker leveraging a franchise model and partnerships with independent agencies to deepen penetration in the P&C market, providing 2026–2027 revenue and EPS estimates (359.1 and 428.5 million; 1.80 and 2.15 EPS) and setting one‑ and two‑year price targets of 90 and 107, while acknowledging its high current P/E of 58 and lack of dividend.